Ticker
PRMECompany Name
PRIME MEDICINE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 279.01M | $ 67.5M | 24.19% |
3/31/2025 | $ 328.16M | $ 105.94M | 32.28% |
12/31/2024 | $ 297.51M | $ 196.54M | 66.06% |
9/30/2024 | $ 332.78M | $ 132.04M | 39.68% |
6/30/2024 | $ 259.7M | $ 69.1M | 26.61% |
3/31/2024 | $ 311.38M | $ 107.66M | 34.57% |
12/31/2023 | $ 193.85M | $ 55.07M | 28.41% |
9/30/2023 | $ 239.15M | $ 57.45M | 24.03% |
6/30/2023 | $ 280.87M | $ 134.07M | 47.74% |
3/31/2023 | $ 316.95M | $ 146.96M | 46.37% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PRIME MEDICINE INC is calculated as follows: CashnEq [ $ 105.73M ] / Assets [ $ 247.6M ]
(=) Cash to Assets [ 42.7% ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.8% |
average | 9.79% |
median | 6.44% |
std | 9.55% |